Trials / Conditions / Frontotemporal Dementia (FTD)

Frontotemporal Dementia (FTD)

17 registered clinical trials studyying Frontotemporal Dementia (FTD) — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a NCT07314190	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	—
Recruiting	Transcranial Alternating Current Stimulation in Frontotemporal Dementia NCT07505784	IRCCS Centro San Giovanni di Dio Fatebenefratelli	N/A
Not Yet Recruiting	Digital Measurements of Motor and Voice Functions in FTD NCT07333898	BioSensics	—
Enrolling By Invitation	Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers a NCT07239843	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	—
Enrolling By Invitation	Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients NCT07200739	Zealand University Hospital	—
Not Yet Recruiting	Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients NCT06978946	RenJi Hospital	N/A
Recruiting	Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia NCT06604520	Johns Hopkins University	Phase 2
Recruiting	Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches NCT06856850	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	—
Recruiting	Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Earl NCT06803784	Neuromed IRCCS	—
Recruiting	[18F]ACI-19626 PET in TDP-43 Proteinopathies NCT06891716	AC Immune SA	EARLY_Phase 1
Withdrawn	Predict to Prevent PGRN Disease NCT06711510	Assistance Publique - Hôpitaux de Paris	N/A
Enrolling By Invitation	The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias NCT06826157	IRCCS San Raffaele	N/A
Completed	A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease NCT07307872	Amoneta Diagnostics SAS	—
Completed	Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia NCT02862210	Columbia University	Phase 2
Recruiting	Comprehensive Assessment of Neurodegeneration and Dementia NCT03402919	McGill University	—
Completed	Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations NCT02676843	Columbia University	Phase 2
Completed	Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) NCT02365922	University of California, San Francisco	—